Sun recalls Nimodine capsules; FDA to study supplement safety; Tetracycline shortage persists in U.S.;

 @EricPFierce: Orphan drugs have become a key product for many companies. See why: Special report | Follow @EricPFierce

> India's Sun Pharma has recalled lots of brain hemorrhage drug Nimodine capsules in the U.S. market due to "crystallisation.'' Report

> The FDA is taking action against makers of a number of "illegal" products that claim to be treatments for diabetes. Release

> A shortage of tetracycline in the U.S. is persisting. Story

> Indian drugmaker Lupin says it has received FDA approval for a generic version of the diabetes drug Glumetza ER tablets. Report

> The FDA will hold a meeting to evaluate how to improve the safety of supplements. Story

And Finally... GlaxoSmithKline's ($GSK) problems in China appear to extend beyond drug marketing. Story